Medication info

Monoka Tablet 10mg (Montelukast Sodium)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Montelukast Sodium›10.4mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Beige, rounded square film-coated tablets
Packaging
30 tablets (10 tablets/PTPX3), 28 tablets (7 tablets/PTPX4)
Approval status
Approval withdrawn

MFDS item code 202003916 · Approved 2020.05.27

This product's status changed to Approval withdrawn on 2024.11.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention and maintenance treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
Who takes it
Adults · Children
Adult dose
This medicine is taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. 10 mg tablet — Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film — Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. ○ Directions for taking the dry syrup (syrup only) For administration, empty 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before taking. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this medicine suspended in water for a prolonged period. ○ Directions for taking the granules (granules only) The 4 mg granules of this medicine may be taken orally directly or mixed with a small amount (approximately 5 mL) of soft food, such as infant food, breast milk, or porridge, at room temperature or cooler. Do not open the package until immediately before taking. After opening, immediately (within 15 minutes) mix with infant food, breast milk, or food, or take the entire contents as is. Do not leave this medicine mixed with infant food, breast milk, or food for a prolonged period; discard any remaining portion. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.
Child dose
5 mg chewable tablet — Children 6~14 years of age: Chew 5 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg chewable tablet — Children 2~5 years of age: Chew 4 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating tablet — Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and, once disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating tablet — Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and, once disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating film — Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating film — Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg dry syrup — Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg granules, asthma — Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. 4 mg granules, asthma — Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. 4 mg granules, allergic rhinitis — Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. 4 mg granules, allergic rhinitis — Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Prevention and maintenance treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis

  • Asthma
  • allergy rhinitis symptoms
View approved original text

This drug helps prevent and continuously treat asthma. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.

How to take

Adult dose

This medicine is taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. 10 mg tablet — Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film — Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. ○ Directions for taking the dry syrup (syrup only) For administration, empty 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before taking. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this medicine suspended in water for a prolonged period. ○ Directions for taking the granules (granules only) The 4 mg granules of this medicine may be taken orally directly or mixed with a small amount (approximately 5 mL) of soft food, such as infant food, breast milk, or porridge, at room temperature or cooler. Do not open the package until immediately before taking. After opening, immediately (within 15 minutes) mix with infant food, breast milk, or food, or take the entire contents as is. Do not leave this medicine mixed with infant food, breast milk, or food for a prolonged period; discard any remaining portion. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.

Child dose

5 mg chewable tablet — Children 6~14 years of age: Chew 5 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg chewable tablet — Children 2~5 years of age: Chew 4 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating tablet — Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and, once disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating tablet — Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and, once disintegrated, take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating film — Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating film — Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg dry syrup — Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg granules, asthma — Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. 4 mg granules, asthma — Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. 4 mg granules, allergic rhinitis — Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. 4 mg granules, allergic rhinitis — Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.

Precautions

This drug contains the artificial sweetener aspartame, and patients with the hereditary condition phenylketonuria should avoid taking it. Daily intake of aspartame should not exceed the recommended limits set by WHO, with a maximum intake of up to 2.4g for adults. Patients with allergies to any components of this drug or with genetic issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this drug. Rarely, patients with asthma or allergic rhinitis may experience various adverse reactions such as fatigue, headache, abdominal pain, and rash, so consult a physician if symptoms occur. Particularly, as this drug is not intended for the treatment of acute asthma attacks, patients should always carry a fast-acting inhaler for emergencies. Corticosteroid medications for inhalation or oral use should not be abruptly stopped or switched, but should be gradually adjusted according to the physician’s guidance. Patients who have hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications concurrently while taking this drug. Symptoms related to the nervous system, such as restlessness, anxiety, depression, and hallucinations, may occur during the use of this drug, and it is important to inform a physician immediately if such symptoms develop. Pregnant or breastfeeding women should consult a physician before taking this drug and should only use it when necessary. In children, the safety and efficacy may vary by age; therefore, it is essential to follow expert guidance when administering to pediatric patients. There is no specific antidote for overdose, so general symptomatic treatment and clinical monitoring are necessary, and if symptoms are severe, seek medical attention immediately. This drug is sensitive to light, so do not open the packaging until just before taking it, and it is best to take it immediately after opening. Store this drug out of reach of children, and take care not to transfer it to another container.

Side effects

  • Asthenia
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 87 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • ear pain
  • gastrointestinal inflammation
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory infection
  • wheezing
  • otitis media
  • tonsillitis
  • sinusitis
  • headache
  • nosebleed
  • increased bleeding frequency
  • thrombocytopenia
  • hypersensitivity reaction
  • anaphylaxis
  • hepatic eosinophilic infiltration
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • orientation disorder
  • attention deficit
  • sleep disorder
  • hallucination
  • insomnia
  • memory disorder
  • psychomotor hyperactivity
  • somnambulism
  • suicidal urge
  • tic
  • drowsiness
  • perceptual disturbance
  • perception decline
  • convulsive seizure
  • palpitations
  • pulmonary eosinophilia
  • vomiting
  • pancreatitis
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • urticaria
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • nocturia
  • edema
  • systemic eosinophilia
  • vasculitic rash
  • worsening pulmonary symptoms
  • cardiac complications
  • neuropathy
  • thirst
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air, moisture, and light, so it should be stored in a tightly closed container. It is advisable to maintain storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help preserve the effectiveness of the drug for a prolonged period.

Appearance and packaging

Appearance

Beige, rounded square film-coated tablets

Package unit

30 tablets (10 tablets/PTPX3), 28 tablets (7 tablets/PTPX4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.